Learn More
CD143 Mouse anti-Human, Brilliant Violet 711, Clone: BB9, BD Optibuild™
Shop All BD Biosciences ProductsDescription
The BB9 monoclonal antibody specifically binds Angiotensin-converting enzyme (ACE) which is also known as Dipeptidyl carboxypeptidase 1 (DCP1) or CD143. CD143 is a type I transmembrane glycoprotein that functions as a zinc metallopeptidase involved with the metabolism of angiotensin, bradykinin, and other oligopeptides. It is expressed on primitive hematopoietic progenitor cells (HPC). BB9 reacts with stromal cells, a minor subset of human bone marrow cells; it does not react with peripheral blood leucocytes. BB9 recognizes a subset of CD34+CD90+ cells that demonstrate low or absent expression of CD38, low retention of Rhodamine 123 and are Ki-67-negative. CD34+BB9+ cells are able to sustain hematopoiesis in pre-CFU culture stimulated with IL-3, IL-6, G-CSF, and SCF. BB9 also reacts with a subset of CD34+ cells from mobilized peripheral blood. This antibody was generated using human bone marrow-derived stromal cells as immunogen.
Specifications
Specifications
| Antigen | CD143 |
| Classification | Monoclonal |
| Clone | BB9 |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Violet 711 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Gene Alias | ACE1, DCP, DCP1, Kininase II, ICH, MVCD3, peptidase P |
| Host Species | Mouse |
| Immunogen | Human bone marrow-derived stromal cells |
| Purification Method | Affinity Purified |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.